108 related articles for article (PubMed ID: 3433308)
21. [Molecular organization and functions of the protein toxins of the causative agents of cholera and plague].
Efremenko VI
Zh Mikrobiol Epidemiol Immunobiol; 1983 Nov; (11):7-13. PubMed ID: 6362301
[No Abstract] [Full Text] [Related]
22. A monoclonal antibody for the specific diagnosis of plague.
Williams JE; Gentry MK; Braden CA; Tyndal GL; Altieri PL; Berman S; Robinson DM
Bull World Health Organ; 1988; 66(1):77-82. PubMed ID: 3260145
[TBL] [Abstract][Full Text] [Related]
23. Purification of two high molecular weight toxins of Clostridium difficile which are antigenically related.
von Eichel-Streiber C; Harperath U; Bosse D; Hadding U
Microb Pathog; 1987 May; 2(5):307-18. PubMed ID: 2467163
[TBL] [Abstract][Full Text] [Related]
24. Characterization of purified Shiga toxin from Shigella dysenteriae 1.
Yutsudo T; Honda T; Miwatani T; Takeda Y
Microbiol Immunol; 1986; 30(11):1115-27. PubMed ID: 3100915
[TBL] [Abstract][Full Text] [Related]
25. Rapid detection of Yersinia pestis with multiplex real-time PCR assays using fluorescent hybridisation probes.
Tomaso H; Reisinger EC; Al Dahouk S; Frangoulidis D; Rakin A; Landt O; Neubauer H
FEMS Immunol Med Microbiol; 2003 Sep; 38(2):117-26. PubMed ID: 13129646
[TBL] [Abstract][Full Text] [Related]
26. Molecular detection of Yersinia pestis isolates of Indian origin by using Pla specific monoclonal antibodies.
Mahesh S; Shukla J; Tuteja U; Batra HV
Comp Immunol Microbiol Infect Dis; 2005 Mar; 28(2):131-44. PubMed ID: 15582689
[TBL] [Abstract][Full Text] [Related]
27. A new purification strategy for fraction 1 capsular antigen and its efficacy against Yersinia pestis virulent strain challenge.
Wang T; Qi Z; Wu B; Zhu Z; Yang Y; Cui B; Dai R; Zhang Q; Qiu Y; Wang Z; Wang H; Guo Z; Wang X; Yang R
Protein Expr Purif; 2008 Sep; 61(1):7-12. PubMed ID: 18539482
[TBL] [Abstract][Full Text] [Related]
28. Combinational deletion of three membrane protein-encoding genes highly attenuates yersinia pestis while retaining immunogenicity in a mouse model of pneumonic plague.
Tiner BL; Sha J; Kirtley ML; Erova TE; Popov VL; Baze WB; van Lier CJ; Ponnusamy D; Andersson JA; Motin VL; Chauhan S; Chopra AK
Infect Immun; 2015 Apr; 83(4):1318-38. PubMed ID: 25605764
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the lipopolysaccharide of Yersinia pestis.
Prior JL; Hitchen PG; Williamson DE; Reason AJ; Morris HR; Dell A; Wren BW; Titball RW
Microb Pathog; 2001 Feb; 30(2):49-57. PubMed ID: 11162185
[TBL] [Abstract][Full Text] [Related]
30. Intra nasal administration of poly-lactic acid microsphere co-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse.
Eyles JE; Sharp GJ; Williamson ED; Spiers ID; Alpar HO
Vaccine; 1998 Apr; 16(7):698-707. PubMed ID: 9562689
[TBL] [Abstract][Full Text] [Related]
31. Comparison of eleven commercially available rapid tests for detection of Bacillus anthracis, Francisella tularensis and Yersinia pestis.
Zasada AA; Formińska K; Zacharczuk K; Jacob D; Grunow R
Lett Appl Microbiol; 2015 May; 60(5):409-13. PubMed ID: 25598285
[TBL] [Abstract][Full Text] [Related]
32. Beta-adrenergic blocking activity of Yersinia pestis murine toxin.
Brown SD; Montie TC
Infect Immun; 1977 Oct; 18(1):85-93. PubMed ID: 198377
[TBL] [Abstract][Full Text] [Related]
33. [Establishment and evaluation of identification method for Yersinia pestis and Yersinia pseudotuberculosis].
Shi G; Zhang Z; Mei L; Chen J; Mei S; Jin D; Zhang Z; Wang Y; Zhang X; Luo Y; Sun J; Yu D; Xia L
Zhonghua Liu Xing Bing Xue Za Zhi; 2015 May; 36(5):496-500. PubMed ID: 26080641
[TBL] [Abstract][Full Text] [Related]
34. The biochemistry and physiology of the plague murine toxin.
AJL SJ; RUST J
Ann N Y Acad Sci; 1960 Nov; 88():1152-4. PubMed ID: 13681868
[No Abstract] [Full Text] [Related]
35. Purification and characterization of alpha-toxin of Clostridium oedematiens type A.
Izumi N; Kondo H; Ohishi I; Sakaguchi G
Jpn J Med Sci Biol; 1983 Jun; 36(3):135-46. PubMed ID: 6632349
[TBL] [Abstract][Full Text] [Related]
36. [Features of regulatory system function in platelets under the effect of plague toxin].
Cherkasova TD; Iurkiv VA
Vopr Med Khim; 1994; 40(6):17-20. PubMed ID: 7618291
[TBL] [Abstract][Full Text] [Related]
37. Purification and characterization of Clostridium perfringens beta toxin.
Sakurai J; Fujii Y
Toxicon; 1987; 25(12):1301-10. PubMed ID: 2449745
[TBL] [Abstract][Full Text] [Related]
38. Cell-mediated protection against pulmonary Yersinia pestis infection.
Parent MA; Berggren KN; Kummer LW; Wilhelm LB; Szaba FM; Mullarky IK; Smiley ST
Infect Immun; 2005 Nov; 73(11):7304-10. PubMed ID: 16239527
[TBL] [Abstract][Full Text] [Related]
39. Properties and pharmacological action of plague murine toxin.
Montie TC
Pharmacol Ther; 1981; 12(3):491-9. PubMed ID: 7025029
[No Abstract] [Full Text] [Related]
40. Virulence of pPst+ and pPst- strains of Yersinia pestis for guinea-pigs.
Samoilova SV; Samoilova LV; Yezhov IN; Drozdov IG; Anisimov AP
J Med Microbiol; 1996 Dec; 45(6):440-4. PubMed ID: 8958247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
